ATO has been shown to induce anti-lymphangiogenic activity in a mouse model of gastric cancer by various mechanisms, including the downregulation of pro-lymphangiogenic factors such as VEGFR-3 and VEGF-C in cancer cells [19]. This evidence concerns the gene VEGFC and cancer.